14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with isoproterenol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, WB; Falck, JR; Henrich, WL | 1 |
| Althurwi, HN; El-Kadi, AO; Elshenawy, OH | 1 |
2 other study(ies) available for 14,15-epoxy-5,8,11-eicosatrienoic acid and isoproterenol
| Article | Year |
|---|---|
Inhibition of renin release by 14,15-epoxyeicosatrienoic acid in renal cortical slices.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Cyclic AMP; Fatty Acids, Unsaturated; In Vitro Techniques; Isoproterenol; Kidney Cortex; Kinetics; Mass Spectrometry; Rats; Renin; Structure-Activity Relationship | 1990 |
Fenofibrate modulates cytochrome P450 and arachidonic acid metabolism in the heart and protects against isoproterenol-induced cardiac hypertrophy.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acid; Cardiomegaly; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Fenofibrate; Gene Expression Regulation, Enzymologic; Hydroxyeicosatetraenoic Acids; Hypolipidemic Agents; Isoproterenol; Male; Rats; Rats, Sprague-Dawley | 2014 |